Vivek Kaimal
Overview
Explore the profile of Vivek Kaimal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1718
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sasu B, Opiteck G, Gopalakrishnan S, Kaimal V, Furmanak T, Huang D, et al.
Mol Ther
. 2022 Dec;
31(3):676-685.
PMID: 36518079
A chromosome 14 inversion was found in a patient who developed bone marrow aplasia following treatment with allogeneic chimeric antigen receptor (CAR) Tcells containing gene edits made with transcription activator-like...
2.
Srinivasan S, Duval M, Kaimal V, Cuff C, Clarke S
J Extracell Vesicles
. 2019 Nov;
8(1):1684425.
PMID: 31741724
Extracellular vesicles (EVs) have great potential as a source for clinically relevant biomarkers since they can be readily isolated from biofluids and carry microRNA (miRNA), mRNA, and proteins that can...
3.
Mashiko S, Edelmayer R, Bi Y, Olson L, Wetter J, Wang J, et al.
J Invest Dermatol
. 2019 Nov;
140(5):1015-1025.e4.
PMID: 31715177
Many psoriasis patients treated with biologics do not achieve total skin clearance. These patients possess residual plaques despite ongoing biologic treatment. To elucidate mechanisms of plaque persistence despite overall good...
4.
Dhanasekaran R, Gabay-Ryan M, Baylot V, Lai I, Mosley A, Huang X, et al.
Oncotarget
. 2018 Feb;
9(5):5517-5528.
PMID: 29464015
Hepatocellular carcinoma (HCC) remains a significant clinical challenge with few therapeutic options. Genomic amplification and/or overexpression of the MYC oncogene is a common molecular event in HCC, thus making it...
5.
Hajarnis S, Lakhia R, Yheskel M, Williams D, Sorourian M, Liu X, et al.
Nat Commun
. 2017 Feb;
8:14395.
PMID: 28205547
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause of renal failure. Here we identify miR-17 as a target for the treatment of ADPKD. We report that...
6.
Huang X, Magnus J, Kaimal V, Karmali P, Li J, Walls M, et al.
Mol Cancer Ther
. 2017 Feb;
16(5):905-913.
PMID: 28167506
Hepatocellular carcinoma (HCC) is one of the most common human malignancies with poor prognosis and urgent unmet medical need. Aberrant expression of multiple members of the miR-17 family are frequently...
7.
Munthe S, Halle B, Boldt H, Christiansen H, Schmidt S, Kaimal V, et al.
J Neurooncol
. 2017 Jan;
132(1):45-54.
PMID: 28091986
Glioblastoma multiforme (GBM) is the most frequent malignant primary brain tumor. A major reason for the overall median survival being only 14.6 months is migrating tumor cells left behind after...
8.
Halle B, Thomassen M, Venkatesan R, Kaimal V, Marcusson E, Munthe S, et al.
J Neurooncol
. 2016 Apr;
128(3):395-404.
PMID: 27063952
Glioblastomas always recur despite surgery, radiotherapy and chemotherapy. A key player in the therapeutic resistance may be immature tumor cells with stem-like properties (TSCs) escaping conventional treatment. A group of...
9.
Bertero T, Cottrill K, Lu Y, Haeger C, Dieffenbach P, Annis S, et al.
Cell Rep
. 2015 Nov;
13(5):1016-32.
PMID: 26565914
Pulmonary hypertension (PH) is a deadly vascular disease with enigmatic molecular origins. We found that vascular extracellular matrix (ECM) remodeling and stiffening are early and pervasive processes that promote PH....
10.
Androsavich J, Sobczynski D, Liu X, Pandya S, Kaimal V, Owen T, et al.
Nucleic Acids Res
. 2015 Sep;
44(2):e13.
PMID: 26384419
Anti-miRNA (anti-miR) oligonucleotide drugs are being developed to inhibit overactive miRNAs linked to disease. To help facilitate the transition from concept to clinic, new research tools are required. Here we...